Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-02

Clinical Trial Update: A Two-Part Study of BOTOX® Therapy for Ischemic Digits [Phase 2]

View source ↗

Summary

Phase 2 trial update of BOTOX therapy for ischemic digits in Raynaud's disease; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Southern Illinois University | Conditions: Raynaud's Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-06-02